Coreweave at $92: The Compelling Bull Case On Offer Right Now
CoreWeave has shed nearly a third of its value since going public, yet its bookings just hit an all-time high. Something in that contradiction points to an opportunity worth understanding before the next earnings report.
At roughly $91.90, CoreWeave (NASDAQ:CRWV) looks compelling. The stock has round-tripped from a filing-day price of $136.80 in May to the low $90s, even as the company logged its strongest bookings quarter ever.
CoreWeave runs an AI-first cloud built on NVIDIA (NASDAQ:NVDA | NVDA Price Prediction) GPUs for customers training and running frontier AI. Revenue scaled to $5.13 billion in FY 2025, up 167.88%, and Q1 2026 revenue hit $2.078 billion, growing 111.69% year over year.
The pullback reflects investor anxiety over losses and capex intensity while the underlying business continues to scale. That gap between narrative and fundamentals is the opportunity.
Why the $99 Billion Backlog Changes the Math
Revenue backlog reached $99.4 billion at the end of Q1 2026, anchored by a $21 billion Meta (NASDAQ:META) commitment signed in March 2026 and roughly $22.4 billion in OpenAI commitments. That is nearly 20 times last year’s revenue, already contracted.
The NVIDIA relationship is a moat few competitors can replicate. CoreWeave was named NVIDIA Exemplar Cloud for inference on GB200 NVL72, closed a $2 billion Class A equity investment from NVIDIA, and expanded the partnership to build more than 5 GW of AI factories by 2030. Bare-metal GPU engineering keeps enterprise workloads sticky.
Shares trade at a 7.51 price-to-sales multiple against triple-digit growth, with adjusted EBITDA hitting $838 million at a 61% margin in Q3 2025.
The Debt-and-Dilution Bear Case
Q1 2026 net loss widened to $740 million from $315 million a year earlier, interest expense doubled to $536 million, and capex jumped to $7.695 billion in a single quarter. Free cash flow ran negative $4.711 billion.
Total liabilities sit at $50.814 billion against $4.759 billion of shareholders’ equity. Customer concentration among hyperscalers, plus a securities fraud class action over data center construction delays, gives bears real ammunition.
Reddit sentiment turned bearish in mid-July, with one wallstreetbets post pointing to CORZ-related data center delays as an overhang, and the composite sentiment score sits at 33.39, bearish with medium confidence.
Why Waiting Has Its Own Logic
CRWV has already rallied 36.55% in a week and remains 13.31% below year-ago levels. The 50-day moving average of $93.75 and 200-day of $94.83 sit right at current price, suggesting an inflection but not a breakout.
Patient investors could reasonably wait for Q2 2026 results to confirm inference-driven margin expansion and for the litigation overhang to clarify.
What the Tape and the Street Say
CRWV currently trades near $91.90 against a consensus analyst target of $138.03, implying roughly 50.2% upside if the Street is right. Coverage is broad: 5 Strong Buy, 21 Buy, 9 Hold, 1 Sell, 1 Strong Sell. The stock is up 28.33% year to date, versus roughly 9% for the S&P 500 over the same stretch. Shares trade at a 7.51 P/S and 8.23 price-to-book, with a 52-week range of $60.55 to $153.20.
Why $92 Reframes the Setup
At $92, CoreWeave looks compelling. The path to appreciation runs through backlog conversion. With $99.4 billion under contract and active power crossing 1 GW toward an 8 GW target by 2030, every quarter of on-time capacity turns signed dollars into recognized revenue. Q1 already showed the shape of it, with operating cash flow of $2.984 billion.
Shares have fallen 32.9% from the May filing price, compressing the multiple even as bookings accelerated. The NVIDIA equity stake and $8.5 billion investment-grade term loan facility signal that the funding stack scales with the opportunity.
What invalidates the thesis: a hyperscaler customer walking, another data center delay disclosed via litigation, or a credit market tightening that lifts financing costs. Track quarterly free cash flow trajectory, backlog additions, and inference mix.
At $92, the tape is finally pricing in tomorrow’s revenue trajectory rather than today’s balance sheet strain.
Contact [email protected] for any questions or corrections.
Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.
Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.
At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.
